首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Runx3 Induces a Cell Shape Change and Suppresses Migration and Metastasis of Melanoma Cells by Altering a Transcriptional Profile
【2h】

Runx3 Induces a Cell Shape Change and Suppresses Migration and Metastasis of Melanoma Cells by Altering a Transcriptional Profile

机译:Runx3通过改变转录剖面诱导细胞形状改变并抑制黑素瘤细胞的迁移和转移

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Runt-related transcription factor-3 (Runx3) is a tumor suppressor, and its contribution to melanoma progression remains unclear. We previously demonstrated that Runx3 re-expression in B16-F10 melanoma cells changed their shape and attenuated their migration. In this study, we found that Runx3 re-expression in B16-F10 cells also suppressed their pulmonary metastasis. We performed microarray analysis and uncovered an altered transcriptional profile underlying the cell shape change and the suppression of migration and metastasis. This altered transcriptional profile was rich in Gene Ontology/Kyoto Encyclopedia of Genes and Genomes (GO/KEGG) annotations relevant to adhesion and the actin cytoskeleton and included differentially expressed genes for some major extracellular matrix (ECM) proteins as well as genes that were inversely associated with the increase in the metastatic potential of B16-F10 cells compared to B16-F0 melanoma cells. Further, we found that this altered transcriptional profile could have prognostic value, as evidenced by myelin and lymphocyte protein (MAL) and vilin-like (VILL). Finally, Mal gene expression was correlated with metastatic potential among the cells and was targeted by histone deacetylase (HDAC) inhibitors in B16-F10 cells, and the knockdown of Mal gene expression in B16-F0 cells changed their shape and enhanced the migratory and invasive traits of their metastasis. Our study suggests that self-entrapping of metastatic Runx3-negative melanoma cells via adhesion and the actin cytoskeleton could be a powerful therapeutic strategy.
机译:Runt相关的转录因子-3(Runx3)是一种肿瘤抑制剂,其对黑素瘤进展的贡献仍不清楚。我们之前证明了B16-F10黑色素瘤细胞中的Runx3重新表达改变它们的形状并减弱它们的迁移。在这项研究中,我们发现B16-F10细胞中的Runx3重新表达也抑制了它们的肺转移。我们进行了微阵列分析,并揭示了细胞形状变化和抑制迁移和转移的改变的转录型材。这种改变的转录谱富含基因本体/ kyoto kyoto的基因和基因组(Go / Kegg)注释,与粘附和肌动蛋白细胞骨架相关,并包括一些主要细胞外基质(ECM)蛋白以及成反比的基因的差异表达基因与B16-F0黑色素瘤细胞相比,与B16-F10细胞的转移电位增加相关。此外,我们发现,这种改变的转录谱可以具有预后值,如髓鞘和淋巴细胞蛋白(MAL)和vilin样(vill)所证明的。最后,MAL基因表达与细胞中的转移潜力相关,并通过B16-F10细胞中的组蛋白脱乙酰酶(HDAC)抑制剂靶向,并且在B16-F0细胞中的MAL基因表达的敲低改变了它们的形状并增强了迁移和侵袭性转移的特征。我们的研究表明,通过粘附和肌动蛋白细胞骨架的转移性Runx3阴性黑色素瘤细胞的自捕获可能是强大的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号